Personalis (PSNL)
(Delayed Data from NSDQ)
$4.73 USD
-0.21 (-4.25%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $4.72 -0.01 (-0.21%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 23% (58 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.83 | 9.99 |
Current Quarter Estimate | -0.33 | 1.59 | 63.00 |
Year Ago Quarter Estimate | -0.51 | -0.94 | 52.25 |
Next Quarter Estimate | -0.32 | 1.70 | 66.00 |
Next Year Estimate | -1.11 | 6.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 47.00 | 21.40 | 15.67 |
Next Year | 3.48 | 6.10 | 11.34 |
Last 5 Years | NA | 0.10 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 3.22 |
Price/Book (MRQ) | 2.19 | 1.84 |
Price/Cash Flow (MRFY) | NA | 10.57 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -101.78% | NA |
Return on Equity (TTM) | -56.87% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.